Cannabinoid Derivatives Promising for Treatment of Alzheimers?

Share the love

A recent study from the University of Göttingen shows promise and the need for further study regarding the use of a synthetic form of tetrahydrocannabinol in the treatment of Alzheimer’s in mice. Treated mice lost less brain matter compared to the placebo group and also did not accumulate sticky plaque associated with Alzheimer’s.  The study (Effects of cannabidiol and tetrahydrocannabinol treatment on memory function, neuron loss and molecular signature in a mouse model of Alzheimer’s disease) was presented and discussed with caution at a recent Society for Neuroscience meeting in San Diego, according to NPR.

Leave a Reply